ArticleThoracic cancer2020

Role of YES1 amplification in EGFR mutation-positive non-small cell lung cancer: Primary resistance to afatinib in a patient.

Junyan Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.